4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000947871-25-001045
Director sold 108,073 shares at an average $44.55 ($4,814,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2025-11-24 | Sale 10b5-1 | −94,583 | $44.54 | $4,212,727 | 3,610,376 | I |
| ORBIMED ADVISORS LLC Director | 2025-11-25 | Sale 10b5-1 | −11,890 | $44.60 | $530,294 | 3,598,486 | I |
| ORBIMED ADVISORS LLC Director | 2025-11-26 | Sale 10b5-1 | −1,600 | $44.49 | $71,184 | 3,596,886 | I |
| Open-market sales · 108,073 sh · avg $44.55 · $4,814,205 | |||||||
Loading xslF345X05/ownership.xml…